Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
GLOBETECH PUBLISHING LLC
FOCUS DIAGNOSTICS, INC.

Genetic Mutations Linked to Autism Subtype

By Labmedica International staff writers
Posted on 17 Jul 2014
Illumina HiSeq 2500 sequencing system
The HiSeq 2500 sequencing system (Photo courtesy of Illumina)
Autism spectrum disorder (ASD) is a heterogeneous disorder with significant genotypic and phenotypic complexity, and definitive cause of autism to a genetic mutation has been revealed.

Previously identified genetic events like Fragile X, which account for a greater number of autism cases, are associated with other impairments, such as intellectual disability, more than autism, while some will have autism marked by gastrointestinal disorders, a larger head and wide set eyes.

In collaboration involving 13 institutions around the world, a study was made of 6,176 children with autism spectrum disorder. Led by scientists from the University of Washington (Seattle, WA, USA) they collected blood samples and genomic DNA was isolated. Molecular inversion probes (MIP) were performed using HiSeq-based sequencing (Illumina; San Diego, CA, USA) and analyzed. They utilized a custom 8 × 60K comparative genomic hybridization (CGH) array (Agilent, Santa Clara, CA, USA) with 150 base pair (bp) probe spacing across the gene body of a specific gene and predicted neighboring regulatory elements.

The scientists found that 15 of 6,176 children with ASD had a mutation in the gene encoding for chromodomain-helicase-DNA-binding protein 8 (CHD8) and all these cases had similar characteristics in appearance and issues with sleep disturbance and gastrointestinal problems. They identified a total of 15 independent mutations and no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings. In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints.

The most commonly researched genetic events associated with autism are chromosomal re-arrangements, called "copy number variations," in which a chunk of chromosome is copied or deleted, but no one rearrangement affects more than 1% of all autism cases. While these copy number events are associated with autism, they do not have a definitive link, or as they say among scientists, a “strong penetrance.”

Raphael Bernier, PhD, a professor of psychiatry and the lead author of the study said, “We finally got a clear cut case of an autism specific gene. This will be a game changer in the way scientists are studying autism. Although less than half a percent of all kids will have this kind of autism related to the CHD8 mutation, there are lots of implications from this study.” The study was published on July 3, 2014, in the journal Cell.

Related Links:

University of Washington 
Illumina 
Agilent  




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


MEDLAB Asia
CELLAVISION AB
KARL HECHT GMBH & CO KG

Channels

Industry News

view channel
Image: Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay, a companion diagnostic immunohistochemical test in the final stages of the FDA premarket approval process (Photo courtesy of Ventana Medical Systems and PRNewsFoto).

Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients

Ventana Medical Systems, Inc. (Tucson, AZ, USA) has announced its US Food & Drug Administration (FDA) final stage submission for premarket approval (PMA) of its companion diagnostic (CDx) immunohistochemistry... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
18 Mar 2015 - 20 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.